OGXI : Summary for OncoGenex Pharmaceuticals Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 42 mins

OncoGenex Pharmaceuticals, Inc. (OGXI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.60-0.03 (-5.51%)
At close: 4:00PM EST
People also watch
THLDRPRXONTXOPXACYCC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.63
Open0.62
Bid0.56 x 5000
Ask0.69 x 3300
Day's Range0.58 - 0.63
52 Week Range0.33 - 1.42
Volume480,268
Avg. Volume826,875
Market Cap18.01M
Beta2.31
PE Ratio (TTM)-1.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group11 days ago

    OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement

    OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement

  • PR Newswire11 days ago

    OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement

    BOTHELL, Wash. and VANCOUVER, British Columbia and MILL VALLEY, Calif., Jan. 5, 2017 /PRNewswire/ --OncoGenex Pharmaceuticals, Inc. (OGXI) ("OncoGenex"), a publicly held oncology biopharmaceutical company, and Achieve Life Science, Inc. ("Achieve"), a privately held specialty pharmaceutical company, announced today that they have entered into a definitive merger agreement under which OncoGenex will acquire Achieve in an all-stock transaction. Upon completion of the proposed merger, Achieve's equity holders are expected to own 75% of the combined company's outstanding shares and current stockholders of OncoGenex are expected to own the remaining 25% of the combined company's outstanding shares.  Following completion of the merger, OncoGenex Pharmaceuticals, Inc. will be renamed Achieve Life Sciences, Inc.

  • PR Newswire2 months ago

    OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016

    BOTHELL, Wash. and VANCOUVER, British Columbia, Nov. 10, 2016 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced its third quarter 2016 financial results.   Recent Events In ...